Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | paired box 8 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | pax transcription factor protein 2 | Get druggable targets OG5_139945 | All targets in OG5_139945 |
Onchocerca volvulus | Get druggable targets OG5_139945 | All targets in OG5_139945 | |
Brugia malayi | Pax transcription factor protein 2 | Get druggable targets OG5_139945 | All targets in OG5_139945 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CMGC family protein kinase | 0.0253 | 0.0402 | 0.1422 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0253 | 0.0402 | 0.1422 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0253 | 0.0402 | 1 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0253 | 0.0402 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.1078 | 0.2561 | 0.2421 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.3921 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0253 | 0.0402 | 0.1422 |
Schistosoma mansoni | dual specificity serine/threonine tyrosine kinase | 0.1078 | 0.2561 | 0.2421 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0253 | 0.0402 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0253 | 0.0402 | 0.0222 |
Trichomonas vaginalis | cyclin B, putative | 0.0169 | 0.0185 | 0.0557 |
Toxoplasma gondii | cell-cycle-associated protein kinase CDK, putative | 0.0253 | 0.0402 | 0.5 |
Brugia malayi | cell division control protein 2 homolog | 0.0253 | 0.0402 | 0.0222 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0253 | 0.0402 | 0.0222 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0253 | 0.0402 | 0.0222 |
Echinococcus multilocularis | dual specificity serine:threonine tyrosine | 0.1078 | 0.2561 | 0.2421 |
Trichomonas vaginalis | cyclins, putative | 0.0169 | 0.0185 | 0.0557 |
Trichomonas vaginalis | cyclins, putative | 0.0169 | 0.0185 | 0.0557 |
Trichomonas vaginalis | cyclin B, putative | 0.0169 | 0.0185 | 0.0557 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.0185 | 0.0185 |
Trichomonas vaginalis | cyclin B, putative | 0.0169 | 0.0185 | 0.0557 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0253 | 0.0402 | 1 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0253 | 0.0402 | 0.0222 |
Loa Loa (eye worm) | TTK protein kinase | 0.1078 | 0.2561 | 0.2561 |
Trichomonas vaginalis | cyclin A, putative | 0.0169 | 0.0185 | 0.0557 |
Giardia lamblia | Kinase, CMGC CDK | 0.0253 | 0.0402 | 0.0916 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0253 | 0.0402 | 0.0222 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0253 | 0.0402 | 0.0222 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.3921 | 1 | 1 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0253 | 0.0402 | 1 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.3921 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.3921 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.0185 | 0.0185 |
Plasmodium falciparum | protein kinase 5 | 0.0253 | 0.0402 | 0.5 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.3921 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0226 | 0.0334 | 0.0334 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0253 | 0.0402 | 0.0222 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0253 | 0.0402 | 1 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0253 | 0.0402 | 1 |
Echinococcus granulosus | cyclin dependent kinase | 0.0253 | 0.0402 | 0.0222 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.3921 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.1078 | 0.2561 | 1 |
Echinococcus granulosus | dual specificity serine:threonine tyrosine | 0.1078 | 0.2561 | 0.2421 |
Onchocerca volvulus | 0.0291 | 0.0502 | 0.0323 | |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0253 | 0.0402 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0253 | 0.0402 | 0.0916 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0253 | 0.0402 | 0.0402 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0291 | 0.0502 | 0.0502 |
Brugia malayi | Pax transcription factor protein 2 | 0.0291 | 0.0502 | 0.0323 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0253 | 0.0402 | 0.0402 |
Trichomonas vaginalis | cyclins, putative | 0.0169 | 0.0185 | 0.0557 |
Onchocerca volvulus | Dual specificity protein kinase TTK homolog | 0.1078 | 0.2561 | 0.2421 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0253 | 0.0402 | 1 |
Plasmodium vivax | protein kinase Crk2 | 0.0253 | 0.0402 | 0.5 |
Trichomonas vaginalis | cyclin B, putative | 0.0169 | 0.0185 | 0.0557 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0253 | 0.0402 | 0.0222 |
Giardia lamblia | Kinase, TTK | 0.1078 | 0.2561 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.1078 | 0.2561 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0253 | 0.0402 | 0.0222 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0253 | 0.0402 | 0.0402 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.3921 | 1 | 1 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0253 | 0.0402 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0253 | 0.0402 | 0.0222 |
Trichomonas vaginalis | cyclins, putative | 0.0169 | 0.0185 | 0.0557 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | = 3.44 uM | PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.